Cheshire, UK--(Marketwire - August 21, 2007) -
Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 21 August 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that on 20 August 2007, in accordance with the
Transparency Obligations Directive, a notification of interest in the ordinary
share capital of the Company was received from AXA Investment Managers UK
Limited on behalf of AXA S.A. and its Group companies ("AXA"). The notification
follows an increase in the Indirect voting rights of AXA from 10.94% to 11.01%
of total voting rights. Details of their interest are as follows:
1. Reason for the notification (please tick the appropriate box or boxes)
An acquisition of voting rights X
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its
notification obligation: group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 19 August 2007
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 20 August 2007
6. Threshold(s) that is/are crossed or reached: 11%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
0702920 37,631,294 37,631,294 345,879 345,879 37,346,514 0.10% 11.01%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights
instrument Period/ Date that may be acquired if
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
37,692,393 11.11%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
Name of Company/Fund Number of Shares % of issued share capital
AXA UK Investment Co ICVC 1,121,588 0.33061
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 16,250 0.00479
Direct
Sun Life Unit Assurance Ltd 53,913 0.01589
FTSE All Share Tracker
Direct
Sun Life Pensions Management 275,716 0.08127
FTSE All Share Tracker
Direct
AXA Framlington 727,476 0.21444
SEI UK Equity
Indirect
AXA Framlington 1,879,667 0.55408
Throgmorton Trust
Indirect
AXA Framlington 15,013,453 4.42557
UK Select Ops
Indirect
AXA Framlington 13,753,131 4.05406
Equity Income
Indirect
AXA Framlington 1,692,599 0.49893
Managed Balanced
Indirect
AXA Framlington 1,379,667 0.40669
UK Smaller Companies
Indirect
AXA Framlington 394,259 0.11622
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 176,049 0.05189
BAE Systems 2000 Pensions Fund
Indirect
Framlington onshore private clients 1,152,375 0.33969
Indirect
Framlington onshore private clients 56,250 0.01658
Indirect
Total Direct 345,879 0.10196
Total Indirect 37,346,514 11.00876
TOTAL 37,692,393 11.11071
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange